Overexpression of p53: A rare event in a large series of white patients with hepatocellular carcinoma

Hepatology

Volumn 16, Issue 5, 1992, Pages 1171-1175

  Laurent‐Puig, Pierre ^a   Flejou, Jean‐François ^a   Fabre, Monique ^a   Bedossa, Pierre ^b   Belghiti, Jacques ^b   Gayral, François ^c   Franco, Dominique ^c  

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; MUTANT PROTEIN;

ADULT; ARTICLE; CAUCASIAN; DIETARY INTAKE; FEMALE; GENE EXPRESSION; GENE MUTATION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPACIVIRUS; HEPATITIS ANTIBODIES; HUMAN; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MIDDLE AGE; MUTATION; PROTEIN P53; SUPPORT, NON-U.S. GOV'T;

EID: 0026497325     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840160511     Document Type: Article

References (53)

1. Localization of gene for human p53 tumour antigen to band 17p13
2. The p53 tumor suppressor gene
3. Mutations in the p53 gene occur in diverse human tumor types
4. Mutations in the p53 gene are frequent in primary, resected non small cell lung cancer
5. Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small lung cancer
6. Increased expression of mutant forms of p53 oncogene in primary lung cancer
7. The p53 gene is very frequently mutated in small‐cell lung cancer with distinct nucleotide substitution pattern
8. Chromosome 17p and p53 gene mutations in colorectal carcinomas
9. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
10. Mutations of the p53 gene, including an intronic point mutation, in colorectal tumors
11. Constant denaturant gel electrophresis as a rapid screening technique for p53 mutations
12. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumors
13. Frequent mutation of the p53 gene in human esophagal cancer
14. Expression of p53 in premalignant and malignant squamous epithelium
15. Oligomerization of oncoprotein p53
16. When the products of oncogenes and antioncogenes meet
17. p53 mutations in colorectal cancer
18. p53 expression in breast cancer
19. Expression of the nuclear oncogene p53 in colon tumours
20. Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro
21. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies
22. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer
23. Overexpression and mutation of p53 in epithelial ovarian cancer
24. p53 expression in colorectal tumors
25. p53 in colorectal cancer: clinicopathological correlation and prognostic significance
26. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas
27. Expression of mutant p53 in melanoma
28. Detection of p53 in primary lung tumors and non small cell lung carcinoma cell lines
29. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines
30. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
31. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
32. Aberrations of tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas
33. A frequent target for genetic abnormalities in human hepatocellular carcinomas (HCC) in Britain?
34. p53 mutation in hepatocellular carcinoma after aflatoxin exposure
35. Primary carcinoma of the liver. A study of 100 cases among 48900 necropsies
36. The labeled antigen method of immunoperoxidase staining
37. Isolation of human‐p53‐specific monoclonal antibodies and their use in the studies of human p53 expression
38. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines
39. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens
40. p53: a frequent target for genetic abnormalities in lung cancer
41. Rearrangement of the p53 gene in human osteogenic sarcoma
42. p53 mutation, ras mutations, and p53‐heat shock protein complexes in human lung carcinoma cell lines
43. Association of human papillomavirus types 16 and 18 E6 proteins with p53
44. Mutant p53 proteins bind hsp 72/73 cellular heat shock‐related proteins in SV40‐transformed monkey cells
45. Degradation of nuclear oncoproteins by the ubiquitin system in vitro
46. p53 and Kirsten‐ras mutation in human mesothelioma cell lines
47. Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma
48. Hepatitis B virus integration event in human chromosome 17p near p53 gene indentifies the region of the chromosome commonly deleted in virus positive hepatocellular carcinomas
49. Hepatitis B virus integration in a cyclin A gene in hepatocellular carcinoma
50. Transcriptional activation of homologous and heterologous genes by hepatitis B virus x gene product in cells permissive for viral replication
51. A trans‐activator function is generated by integration of hepatitis B virus pre‐S/S sequences in human hepatocellular carcinoma DNA
52. Trans‐activation function of a 3′ truncated x gene‐cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues
53. Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma